Stockscreener 앱 받기
3.99
0.75%
-0.03
시간 외 거래:
3.99
Adc Therapeutics Sa 주식(ADCT)의 최신 뉴스
Will ADC Therapeutics SA stock sustain high P E ratiosMarket Activity Report & Risk Controlled Swing Trade Alerts - mfd.ru
What drives ADC Therapeutics SA’s stock priceTrade Exit Report & Community Trade Idea Sharing - mfd.ru
Can ADC Therapeutics SA stock outperform in 2025 bull marketEarnings Miss & Safe Capital Growth Stock Tips - mfd.ru
Will ADC Therapeutics SA stock hit new highs in YEARQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - mfd.ru
Analysts Set ADC Therapeutics SA (NYSE:ADCT) Price Target at $7.50 - Defense World
Bond Watch: Is ADC Therapeutics SA a stock for growth or value investorsGDP Growth & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5%Here's Why - MarketBeat
ADC Therapeutics (NYSE:ADCT) Trading Down 4.5%Here's What Happened - MarketBeat
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5% – Here’s Why - Defense World
Little Excitement Around ADC Therapeutics SA's (NYSE:ADCT) Revenues - 富途牛牛
ADC Therapeutics SA's (NYSE:ADCT) Price Is Right But Growth Is Lacking - simplywall.st
Update On ADCs: Sales, Deals, Targets And Approvals - Citeline News & Insights
ADC Therapeutics Grants Stock Options to New Employees - Intellectia AI
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - Finviz
ADC Therapeutics (ADCT) upgraded to buy: Here's why - MSN
Growth Review: Can ADC Therapeutics SA continue delivering strong returns2025 Major Catalysts & Technical Pattern Recognition Alerts - baoquankhu1.vn
Has ADC Therapeutics (ADCT) outpaced other medical stocks this year? - MSN
Is ADC Therapeutics SA stock a good dividend stockNew Guidance & High Accuracy Swing Entry Alerts - mfd.ru
$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium - marketscreener.com
Has ADC Therapeutics (ADCT) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Can ADC Therapeutics SA expand its profit marginsTrade Entry Report & Long-Term Growth Stock Strategies - mfd.ru
Does ADC Therapeutics SA align with a passive investing strategyJuly 2025 Institutional & Capital Efficient Trading Techniques - mfd.ru
Will ADC Therapeutics SA benefit from sector rotation2025 Market Overview & Long-Term Investment Growth Plans - mfd.ru
Moving Averages: Why is ADC Therapeutics SA stock going upStock Surge & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Risk Off: Is ADC Therapeutics SA stock showing strong momentumPortfolio Gains Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Weekly Trades: Can ADC Therapeutics SA continue delivering strong returnsLayoff News & Verified Entry Point Detection - mfd.ru
Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - PR Newswire
ADC Therapeutics Faces Securities Fraud Investigation, Stock Drops 14.13% - intellectia.ai
Breakouts Watch: Will ADC Therapeutics SA benefit from sector rotationWeekly Stock Report & Growth Oriented Trade Recommendations - baoquankhu1.vn
Insider Trends: Can ADC Therapeutics SA disrupt its industryQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Is ADC Therapeutics SA stock attractive for retirement portfoliosWeekly Gains Report & Real-Time Volume Surge Alerts - bollywoodhelpline.com
Short Interest in ADC Therapeutics SA (NYSE:ADCT) Drops By 47.2% - MarketBeat
ADCT: Zynlonta's pivotal trials aim to transform its market reach and drive major growth from 2027 - TradingView
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - sharewise.com
Bull Bear: Why ADC Therapeutics SA stock could benefit from AI revolution2025 Risk Factors & Weekly High Momentum Picks - Bộ Nội Vụ
ADC Therapeutics posts preliminary 2025 revenue of about $73M - MSN
ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy - TipRanks
How geopolitical tensions affect ADC Therapeutics SA stock2025 Sector Review & Technical Buy Zone Confirmations - Улправда
Can ADC Therapeutics SA Common Shares stock sustain margin levelsCEO Change & Low Drawdown Trading Techniques - ulpravda.ru
Is ADC Therapeutics SA Common Shares stock testing key supportQuarterly Market Review & Free High Accuracy Swing Entry Alerts - Улправда
ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook - The Globe and Mail
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Sahm
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Ye - GuruFocus
Can ADC Therapeutics SA stock rebound after recent weakness2025 Winners & Losers & Free Reliable Trade Execution Plans - Улправда
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates - PR Newswire
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
ADC Therapeutics SA Common Shares (NY: ADCT - markets.financialcontent.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC ... - Bluefield Daily Telegraph
1.12%
0.87%
자본화:
|
볼륨(24시간):